You are here

  • Home
  • Archive
  • Volume 76, Issue 8
  • Long-term outcome is better when a methotrexate-based treatment strategy is combined with 10 mg prednisone daily: follow-up after the second Computer-Assisted Management in Early Rheumatoid Arthritis trial

Article info

Article menu
Download PDFPDF
Clinical and epidemiological research
Concise report
Long-term outcome is better when a methotrexate-based treatment strategy is combined with 10 mg prednisone daily: follow-up after the second Computer-Assisted Management in Early Rheumatoid Arthritis trial

Authors

  1. Correspondence to M Safy, Department of Rheumatology & Clinical Immunology, F.02.127, University Medical Center Utrecht, Box 85500, Utrecht 3508, GA, The Netherlands; m.safy{at}umcutrecht.nl
View Full Text

Citation

Safy M, Jacobs J, IJff N On behalf of the Society for Rheumatology Research Utrecht (SRU), et al
Long-term outcome is better when a methotrexate-based treatment strategy is combined with 10 mg prednisone daily: follow-up after the second Computer-Assisted Management in Early Rheumatoid Arthritis trial
Annals of the Rheumatic Diseases 2017;76:1432-1435.

Publication history

  • Received October 6, 2016
  • Revised April 4, 2017
  • Accepted April 9, 2017
  • First published April 27, 2017.
Online issue publication 
October 31, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.